Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Current Oncology (Toronto, Ont.)|September 27, 2024
Diagnosis of Pleural Mesothelioma: Is Everything Solved at the Present Time?Elisa Roca, Avinash Aujayeb, Philippe AstoulCancer Treatment Reviews|August 15, 2017
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysisElisa Roca, Cristina Gurizzan, Vito Amoroso, et al.Cancer Treatment Reviews|September 6, 2020
Is DNA repair a potential target for effective therapies against malignant mesothelioma?Ilaria Fuso Nerini, Elisa Roca, Laura Mannarino, et al.Lung Cancer (Amsterdam, Netherlands)|December 5, 2012
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enoughElisa Roca, Sophie Laroumagne, Thomas Vandemoortele, et al.Expert Review of Anticancer Therapy|August 18, 2018
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management optionsSoraya Puglisi, Paola Perotti, Deborah Cosentini, et al.European Radiology|July 10, 2013
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapyMarco Ravanelli, Davide Farina, Mauro Morassi, et al.Respiration; International Review of Thoracic Diseases|January 25, 2014
Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcomaThomas Vandemoortele, Sophie Laroumagne, Elisa Roca, et al.Respiration; International Review of Thoracic Diseases|May 14, 2015
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?Valentina Pinelli, Elisa Roca, Silvia Lucchini, et al.Journal of Oncology|July 9, 2009
Clinical Significance of Skin Toxicity due to EGFR-Targeted TherapiesMonica Giovannini, Vanesa Gregorc, Carmen Belli, et al.Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional caseElisa Roca, Marta Pozzari, William Vermi, et al.Pageof 7